Welcome to the Hope Bio Blog

By the Hope Biosciences Editorial Team HOUSTON, TX April 20, 2020 - Hope Biosciences announces FDA authorization of their third clinical trial for COVID-19. This study will be conducted in collaboration with Advanced Diagnostics Healthcare (ADH) at River Oaks Hospital and Clinics. The hospital has an entire floor dedicated to treating COVID-19 patients, with staff specifically trained to care for these patients. The goal of this collaboration is to provide cutting-edge thera

By the Hope Biosciences Editorial Team Update! Results of one of the trials mentioned in this announcement have since been published in Frontiers in Medicine, available at this link. HOUSTON, TX, April 13, 2020 - Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today announced that FDA has authorized a Phase II clinical trial evaluating the safety and efficacy of Hope Biosciences’ allogeneic,

By the Hope Biosciences Editorial Team Update! Results of one of the trials mentioned in this announcement have since been published in Frontiers in Medicine, available at this link. HOUSTON, TX, April 06, 2020 – Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today announced that FDA has authorized a Phase II clinical trial evaluating efficacy and safety of Hope Biosciences’ autologous, adi